Nonprofit naloxone maker celebrates FDA approval by donating 200,000 doses
Naloxone is viewed as a critical way of fighting the opioid epidemic. But its high price has hurt efforts to distribute it en masse.
A nonprofit naloxone manufacturer is celebrating its recent market approval by giving away 200,000 doses of its over-the-counter nasal spray.
Harm Reduction Therapeutics said in a statement that it will donate nearly a quarter-million doses of its new product to the Remedy Alliance, an organization devoted to affordable naloxone access. The announcement comes on the heels of the Food and Drug Administration’s approval of Harm Reduction Therapeutics’ product RiVive, a new nasal naloxone spray used to reverse opioid overdose.
What's Your Reaction?
